2022 Summit
current
03/16/2022 3:00 pm ET
Register for the 2022 Migraine World Summit today! Registration is free and gives you access to all the interviews each day as they happen.
You will already have an active registration if you've registered for the Migraine World Summit in past years. Please login to your existing account to use that registration.
Schedule
Array
(
[0] => 3659
[1] => 3660
[2] => 3661
[3] => 3662
[4] => 3663
[5] => 3664
[6] => 3665
[7] => 3666
[8] => 3667
)
1
Day 1 (2022) |
View Day | ||
|---|---|---|---|
|
Learning the Full Impact of Migraine Through Patient Voices |
Rebecca Erwin Wells, MD, MPH, FAHSAssociate Professor; Founder & Director, Comprehensive Headache Program |
Watch Interview |
|
Expert Tips to Manage Persistent Migraine Pain |
Jessica Ailani, MDDirector, Headache Center |
Watch Interview |
|
Migraine Long Haulers: Lasting Effects |
Matthew Robbins, MDAssociate Professor of Neurology and Residency Program Director |
Watch Interview |
|
The Latest New Treatments for Migraine |
Deborah I. Friedman, MD, MPH, FAANProfessor of Neurology & Ophthalmology |
Watch Interview |
Day 2 (2022) |
View Day | ||
|
Persistent Chronic Migraine Symptoms Between Attacks |
Christine Lay, MD, FAHSProfessor of Neurology, Deborah Ivy Christiani Brill Chair |
Watch Interview |
|
10 Steps to Migraine Management Your Doctor Should be Taking |
Messoud Ashina, MDProfessor of Neurology in the Faculty of Health and Medical Sciences |
Watch Interview |
|
True Resilience: How a Paralympian Wins With Migraine |
Allysa SeelyParatriathlete & Paralympic Gold Medalist |
Watch Interview |
|
When Nothing Works: Treatment-Resistant Chronic Migraine |
Amaal J. Starling, MD, FAHS, FAANNeurologist |
Watch Interview |
Day 3 (2022) |
View Day | ||
|
Complementary and Integrative Treatments for Migraine |
Elizabeth Leroux, MD, FRCPCHeadache Specialist |
Watch Interview |
|
Autoimmune Disease and Migraine: A Closer Look |
Peter McAllister, MD, FAANNeurologist & Director |
Watch Interview |
|
Inflammation Control as Migraine Control |
Gretchen E. Tietjen, MDProfessor Emerita of Neurology |
Watch Interview |
|
Ehlers-Danlos, Connective Tissue Disorders & Migraine |
Vince Martin, MD, AQHDirector |
Watch Interview |
Day 4 (2022) |
View Day | ||
|
Physical Therapy Modalities for Headache & Pain |
Ali Ladak, PT, DPT, PhDLead Therapist |
Watch Interview |
|
Drug-Free Devices for Modulating Migraine |
Deena Kuruvilla, MD, FAHSNeurologist & Director |
Watch Interview |
|
Understanding The Genetics of Headache |
Professor Lyn Griffiths, PhD, BSc HonsDirector, Centre for Genomics & Personalised Health |
Watch Interview |
|
Techniques for Managing Vestibular Migraine |
Michael Teixido, MDAssistant Professor of Otorhinolaryngology |
Watch Interview |
Day 5 (2022) |
View Day | ||
|
Long-Term Effects of New Migraine Medications |
Robert P. Cowan, MDProfessor of Neurology & Neurosciences, Chief, Division of Headache Medicine |
Watch Interview |
|
Strategies to Boost Brain Health |
Krystal L. Culler, DBH, MAFounder & Creative Director |
Watch Interview |
|
New Daily Persistent Headache: Causes, Symptoms & Treatment |
David Dodick, MDProfessor (Emeritus) |
Watch Interview |
|
Food and Diets: A Nutritionist’s Take On How They Affect Migraine |
Margaret Slavin, PhD, RDNAssociate Professor of Nutrition & Food Studies |
Watch Interview |
Day 6 (2022) |
View Day | ||
|
Chronic Cluster Headache |
Christopher Gottschalk, MD, FAHSProfessor of Clinical Neurology; Director, Headache & Facial Pain Program |
Watch Interview |
|
Learning How to Sleep Better with Migraine |
Alex Dimitriu, MDPsychiatrist & Founder |
Watch Interview |
|
How We Got to Now: A History of Migraine |
Katherine Foxhall, PhDHistorian & Author |
Watch Interview |
|
Navigating COVID with Migraine in Europe |
Patricia Pozo-Rosich, MD, PhDHead of Neurology Section & Director, Migraine Adaptive Brain Center |
Watch Interview |
Day 7 (2022) |
View Day | ||
|
Osmophobia: Scent-Induced Migraine |
Frederick Godley, MDFounder & President |
Watch Interview |
|
Chronic Disease on Social Media: Helpful or Harmful? |
Cynthia Armand, MDNeurologist and Headache Specialist |
Watch Interview |
|
Best Practices for Treating Children With Migraine |
Scott W. Powers, PhD, ABPP, FAHSCCRF Endowed Chair & Professor of Pediatrics |
Watch Interview |
|
Women’s Health Inequities and Migraine |
Monica P. Mallampalli, PhDFounder and CEO |
Watch Interview |
Day 8 (2022) |
View Day | ||
|
Staying Hopeful: Treatment Burnout in Chronic Disease |
Dawn C. Buse, PhDPsychologist & Clinical Professor |
Watch Interview |
|
How Women’s Hormones Affect Migraine |
Jelena Pavlović, MD, PhDAssociate Professor |
Watch Interview |
|
The Latest Cannabis Research for Migraine |
Nathaniel M. Schuster, MDAssociate Professor & Associate Clinic Director |
Watch Interview |
|
The Latest Developments in Migraine Research |
Richard B. Lipton, MDProfessor of Neurology & Director of the Montefiore Headache Center |
Watch Interview |
Day 9 (2022) |
View Day | ||
|
Highlights Webinar 2022 |
Paula Dumas & Carl CincinnatoCo-hosts |
Watch Interview |
FAQs
These are common questions and answers that relate to the Summit. If you can’t find a specific question please use the chat widget in the bottom right corner of the page.
Common Questions & Answers
The Extended Edition interviews are available for those who purchase a copy of the event. These are interviews that went over the 30 minute limit for the Summit which were edited to fit into the Summit schedule. The extended editions bonus footage NOT AIRED during the free live event.
In 2022, 26 interviews have extended versions. The remaining six, listed below, are the 30 minute interviews with no extended edition.
- Chronic Disease on Social Media: Helpful or Harmful? | Cynthia E. Armand, MD (Day 7)
- Complementary and Integrative Treatments for Migraine | Elizabeth Leroux, MD, FRCPC (Day 3)
- Ehlers-Danlos, Connective Tissue Disorders & Migraine | Vince Martin, MD (Day 3)
- Osmophobia: Scent-Induced Migraine | Frederick Godley, MD (Day 7)
- True Resilience: How a Paralympian Wins With Migraine | Allysa Seely (Day 2)
- Women’s Health Inequities and Migraine | Monica P. Mallampalli, PhD(Day 7)
The online Migraine World Summit is free to watch during the live event. Each day four interviews are released and are available for 24 hours before the next day's interviews are released.
If you wish to purchase unlimited access to all the interviews, video, audio, and transcripts from this year you can order your own copy. Click here for more details about the All Access or VIP Passes.
Visit the Summit Tips page here or visit the FAQ page for more support. You may also request a 'chat' with our support team using our website chat feature at the bottom right of the screen.
Yes, you can download/print a PDF of the schedule here: Download/Print
Get your own copy of the entire 2022 Summit
- 30+ Expert interviews with audio clips and transcripts
- Unlimited streaming and downloads
- Lifetime access with no annual fee
A special thanks to our sponsors who help make the Migraine World Summit possible.
Sponsors
(Click each sponsor image to learn more)
Lundbeck
Lundbeck is tirelessly dedicated to restoring brain health, so every person can be their best. Consistent with our heritage, we actively seek to establish deep connections with our patient communities to understand how to best meet the needs of the patients we serve. It’s been our privilege to work together with advocacy groups on important initiatives that are tailored to the community. Our latest FDA-approved product, VYEPTI, shows our dedication to providing transformative therapies in brain diseases for patients.
Nurtec ODT (rimegepant) 75mg
Nurtec ODT (rimegepant) is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults and the preventive treatment of episodic migraine in adults. Prescription only. Don’t take if allergic to Nurtec ODT. The most common side effects were nausea, stomach pain/indigestion. See Important Safety Information and Prescribing Information at nurtec.com.
gammaCoreTM (non-invasive vagus nerve stimulator)
A handheld, portable device delivers quick & easy treatments whenever & wherever needed. Take back control of your migraine – treat & prevent multiple types of headache pain via the vagus nerve!
gammaCoreTM (nVNS) activates the vagus nerve with gentle electrical stimulation through the skin to prevent & relieve headache pain. Think of the vagus nerve as the “superhighway” of the nervous system which sends communications between your brain and many parts of the body. Stimulating the vagus nerve blocks pain signals causing the attacks, to help provide fast relief & prevent future attacks.
FDA-cleared in the US & CE-marked in the EU, available in 15+ countries by Prescription / Authorisation. Please see Indications & Important Safety Indications.
Teva
About a billion people around the world are affected by migraine. Many suffer from severe headaches, and others endure debilitating pain, blurred vision, and other side-effects, some for as many as 15 days a month or more. Teva has been providing treatments for diseases of the central nervous system for over thirty years. We are working to bring innovative treatments to those suffering from migraine and headache, as well as bringing greater awareness of the impact these conditions can have on peoples’ lives.
Learn more about Trudhesa for your Migraine Attacks
Impel NeuroPharma is focused on developing transformative therapies for people living with central nervous system (CNS) disorders through the pioneering of an optimized approach to drug delivery. Our therapies are enabled by the Company’s proprietary upper nasal delivery technology, known as the Precision Olfactory Delivery, or POD®, device. The upper nasal space is surrounded by a rich vasculature that has the potential for injection-like absorption, resulting in more rapid and consistent bioavailability and clinical response. While an ideal target for drug delivery, to date no technology has been able to consistently deliver drugs predictably and consistently to the upper nasal area.
Ready to ask your doctor about Trudhesa? Bring this with you!
Trudhesa Prescribing Information: View Here
Lilly
Eli Lilly and Company is proud to sponsor the Migraine World Summit. To learn more about our approved products, click the button link below.
Amgen
Amgen is proud to sponsor the Migraine World Summit. To learn more about our approved product, click the button link below.
AbbVie
AbbVie is proud to sponsor the Migraine World Summit. To learn more about our approved products, click the button link below.
BioDelivery Sciences International (BDSI)
BioDelivery Sciences International, Inc. (NASDAQ: BDSI) is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of differentiated products that address serious and debilitating conditions, including chronic pain, migraine, and opioid-induced constipation.
SEEN
SEEN's fragrance-free hair care is ideal for those who experience fragrance sensitivity or scent-induced migraines. Our fragrance-free, non-medicated, shampoo, conditioner, and styling products will give you stronger, smoother, healthy hair and a healthy scalp without clogging pores or irritating the skin.
Migraine at Work
Migraine doesn't have to derail your career. Nearly every workplace in the country is impacted by migraine disease through absenteeism and presenteeism. Despite the prevalence of the disease, there is a lack of education and awareness around it. In the workplace, this often leads to unintended stigma and bias against employees living with migraine disease. Visit our website to learn more about programs available for both employees and employers.
